Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TP1448 |
Astressin
|
||
Astressin is an amino-terminal truncated analog of CRF that retains high affinity binding to the extracellular domain of the receptor and is believed to act as a neutral competitive antagonist of receptor activation. | |||
TP1448L |
Astressin acetate
Astressin acetate (170809-51-5 Free base) |
CRFR | GPCR/G Protein |
Astressin acetate 是促肾上腺皮质激素释放因子 (CRF) 的拮抗剂,对 CRF 结合蛋白具有低亲和力,对克隆垂体受体具有高亲和力 (Ki = 2 nM)。 | |||
TP2095 |
Astressin 2B
|
||
Potent and selective corticotropin-releasing factor receptor 2 (CRF2) antagonist (IC50 values are 1.3 and > 500 nM for CRF2 and CRF1 respectively). Antagonizes CRF2-mediated inhibition of gastric emptying. | |||
TP2121L |
Sauvagine acetate(74434-59-6 Free base)
|
||
Sauvagine acetate(74434-59-6 Free base) 是一种促肾上腺皮质激素释放因子 (CRF) 受体激动剂。 抑制 125I-[D-Tyr1]astressin 与 hCRF-R1、rCRF-R2a 和 mCRF-R2b 结合的 Ki 值分别为 9.4、9.9 和 3.8 nM。 | |||
TP2121 |
Sauvagine
|
||
Corticotropin-releasing factor (CRF) receptor agonist. Ki values are 9.4, 9.9, and 3.8 nM for inhibition of 125I-[D-Tyr1]astressin binding to hCRF-R1, rCRF-R2a and mCRF-R2b respectively. |